COVID-19
A recent study published in Science Advances has revealed a key mechanism of resistance to the antiviral medication nirmatrelvir (NIR) in the SARS-CoV-2 protease. The research, conducted by a team of scientists at Emory University, found that a specific mutation in the SARS-CoV-2 nsp5 protease, E166V, confers strong resistance to
COVID-19
Researchers from Fudan University in Shanghai, China, have made a groundbreaking discovery in understanding the mechanisms of SARS-CoV-2's spike protein, a key mediator of viral entry and a critical target for drug development. The study, published in the journal Theranostics, reveals that the spike protein undergoes dynamic SUMO
COVID-19
Fresh data on Coronavirus - COVID-19 have been presented in a new report by researchers at Los Alamos National Laboratory. The study highlights the significant role of mathematical models in understanding the natural history of acute SARS-CoV-2 infection, optimizing antiviral treatment strategies, and identifying factors associated with transmission. The research
COVID-19
A team of researchers at the University of Toledo has made a significant breakthrough in understanding the molecular determinants of the SARS-CoV-2 main protease (Mpro), a crucial enzyme for viral replication. The study, published in the journal Molecules, reveals that a systematic investigation into the molecular determinants of Mpro inhibition
COVID-19
The COVID-19 pandemic remains a pressing concern globally due to the rapid emergence of new variants and the development of antiviral drug resistance. Despite mass vaccinations, the pandemic continues to unfold, with researchers emphasizing the urgent need for new antiviral strategies to combat SARS-CoV-2 infections. The use of nirmatrelvir has
COVID-19
New research published in AAPS PharmSciTech has made significant progress in developing a treatment for COVID-19, caused by the coronavirus SARS-CoV-2. The study, conducted by a team of researchers from Mercer University, focused on creating a nebulized Camostat Mesylate (Camo) loaded nanoliposome (Camo-pegNLs) for direct lung delivery to treat SARS-CoV-2
COVID-19
The COVID-19 pandemic has significantly increased global interest in antiviral therapies, and the demand for effective peptide therapeutics derived from natural substances is rapidly rising. Researchers at the Korea Institute of Science and Technology (KIST) have made a groundbreaking discovery by developing a therapeutic substance with both antiviral and tissue
COVID-19
Researchers from the University of Milan have made significant strides in the development of a novel series of indole-based ethyl cinnamate derivatives that have shown promising results in inhibiting the SARS-CoV-2 Main Protease (M) and human cathepsins, essential enzymes involved in viral replication and entry. These findings suggest that these
COVID-19
Researchers from the Federal University of Santa Maria have conducted a study that investigates the potential of ceftaroline fosamil as an inhibitor of SARS-CoV-2 replication. The study highlights the importance of targeting SARS-CoV-2 proteases M^pro and PL^pro in the development of antiviral drugs for COVID-19 treatment. Ceftaroline fosamil,
COVID-19
Investigations into COVID-19 have revealed a new study on the identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches. Researchers from Istanbul University, in collaboration with other institutions, have made significant breakthroughs in the discovery of effective inhibitors for the treatment of COVID-19. The
COVID-19
Research from Tuskegee University emphasizes the pressing need for effective and affordable antiviral drugs to combat RNA viruses, which pose significant challenges due to their rapid mutation rates, high transmissibility, and ability to adapt to host immune responses and antiviral treatments. The World Health Organization has identified several diseases caused
COVID-19
Recent studies have highlighted the COVID-19 pandemic's impact on the environment, particularly the widespread use of chloroquine phosphate (CQP) in aquatic environments. According to a recent report, the use of CQP has led to its elevated levels in the aquatic environment, prompting concerns about its degradation and potential
